Incyte
INCY
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company also conducts commercial and clinical development Read More...Read Less
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 8 hours ago • INCY
Incyte Gets FDA Nod for the Expanded Use of Monjuvi in LymphomaMarket Watch • 1 day ago • INCY
Incyte Lymphoma Treatment Gets FDA ApprovalBusiness Wire • 1 day ago • INCY
Incyte Announces FDA Approval of Monjuvi® (tafasitamab-cxix) in Combination with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular LymphomaZacks Investment Research • 2 days ago • INCY
Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer DiagnosticsCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.